alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › disease-modifying

disease-modifying

3 studies tagged disease-modifying, dated 2022-09-05 to 2024-04-27. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer's disease: a systematic review 2024-04-27
  2. Preparedness of China's health care system to provide access to a disease-modifying Alzheimer's treatment 2023-06-06
  3. Preparedness of the Brazilian health-care system to provide access to a disease-modifying Alzheimer's disease treatment 2022-09-05

Studies

3 studies carry this tag.

Date range

2022 to 2024

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 2
  • Alzheimer's research & therapy 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer's disease: a systematic review

    ✓ Peer-reviewed alzhub usefulness score 74 out of 100. Alzheimer's research & therapy 2024-04-27 Biomarkers

    As the field moves towards primary prevention, we expect an increase in the use of fluid-based biomarkers to determine disease modification.

  2. Preparedness of China's health care system to provide access to a disease-modifying Alzheimer's treatment

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2023-06-06 Biomarkers

    Closing this gap will require the introduction of high-performing blood tests, greater reliance on cerebrospinal fluid (CSF) testing, and expansion of positron emission tomography (PET) capacity.

  3. Preparedness of the Brazilian health-care system to provide access to a disease-modifying Alzheimer's disease treatment

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2022-09-05 Biomarkers

    Brazil has no national dementia strategy or established pathway for evaluation of cognitive concerns, and dementia is typically diagnosed late if at all.

All topic tags with their study counts